Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines

International Journal of Cancer

Volumn 98, Issue 1, 2002, Pages 57-62

  Housseau, Franck ^a   Langer, Daniel A ^a   Oberholtzer, Samuel D ^a   Moorthy, Anitha ^a   Levitsky, Hyam I ^b   Pardoll, Drew M ^b   Topalian, Suzanne L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Costimulation; MHC; Prostate cancer; T lymphocytes; Tumor antigens

Indexed keywords

B7 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; PROTEIN E6; PROTEIN E7; T LYMPHOCYTE RECEPTOR; TRANSFORMING PROTEIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL IMMORTALIZATION; CELL SPECIFICITY; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSTATE CANCER; T LYMPHOCYTE SUBPOPULATION; WART VIRUS;

ANTIGENS, CD80; ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TUMOR CELLS, CULTURED;

EID: 0036498013     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10154     Document Type: Article

References (19)

1. Cancer vaccines
2. Human tumor antigens for cancer vaccine development
3. A listing of human tumor antigens recognized by T cells
4. Vaccine therapy for prostate cancer
5. Generation of PSA-reactive effector cells after vaccination with PSA-based vaccine in patients with prostate cancer
6. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells
7. Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: A phase I/II clinical trial
8. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
9. Development of dendritic cell-based prostate cancer vaccine
10. Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA
11. Dendritic cells injected via different routes induce immunity in cancer patients
12. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimen
13. The E7 gene of human papilloma virus is sufficient for immortalization of human epithelial cells
14. Recognition of a shared human prostate cancer-associated antigen by nonclassical MHC-restricted CD8+ T cells
15. Expansion of human infiltrating lymphocytes for use in immunotherapy trials
16. Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
17. CD28/B7 system of T cell costimulation
18. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class-I matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells
19. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells